These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3334954)
1. Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long-term follow-up. Najean Y; Deschamps A; Dresch C; Daniel MT; Rain JD; Arrago JP Cancer; 1988 Jan; 61(1):89-95. PubMed ID: 3334954 [TBL] [Abstract][Full Text] [Related]
2. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Nand S; Stock W; Godwin J; Fisher SG Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610 [TBL] [Abstract][Full Text] [Related]
3. Cytogenetic studies on acute nonlymphocytic leukemias following polycythemia vera. Berger R; Bernheim A; Flandrin G; Dresch C; Najean Y Cancer Genet Cytogenet; 1984 Apr; 11(4):441-51. PubMed ID: 6704942 [TBL] [Abstract][Full Text] [Related]
4. Acute leukemia in polycythemia vera. Landaw SA Semin Hematol; 1976 Jan; 13(1):33-48. PubMed ID: 766188 [TBL] [Abstract][Full Text] [Related]
5. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera]. Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175 [TBL] [Abstract][Full Text] [Related]
6. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Ellis JT; Peterson P; Geller SA; Rappaport H Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666 [TBL] [Abstract][Full Text] [Related]
7. Leukemic transformation in polycythemia vera: analysis of risk factors. Nand S; Messmore H; Fisher SG; Bird ML; Schulz W; Fisher RI Am J Hematol; 1990 May; 34(1):32-6. PubMed ID: 2327402 [TBL] [Abstract][Full Text] [Related]
8. Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent. Higuchi T; Okada S; Mori H; Niikura H; Omine M; Terada H Cancer; 1995 Jan; 75(2):471-7. PubMed ID: 7812918 [TBL] [Abstract][Full Text] [Related]
9. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia. Bellucci S; Michiels JJ Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614 [TBL] [Abstract][Full Text] [Related]
10. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. Passamonti F; Malabarba L; Orlandi E; Baratè C; Canevari A; Brusamolino E; Bonfichi M; Arcaini L; Caberlon S; Pascutto C; Lazzarino M Haematologica; 2003 Jan; 88(1):13-8. PubMed ID: 12551821 [TBL] [Abstract][Full Text] [Related]
11. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias". Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781 [TBL] [Abstract][Full Text] [Related]
12. [CD7+, CD34+, electronmicroscopically peroxidase-negative acute leukemia transformed from polycythemia vera after 12 years follow-up]. Kuno Y; Takeo T; Kawashima K Rinsho Ketsueki; 1997 Sep; 38(9):782-7. PubMed ID: 9364871 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow findings in blast phase of polycythemia vera. Hidalgo López JE; Carballo-Zarate A; Verstovsek S; Wang SA; Hu S; Li S; Xu J; Zuo W; Tang Z; Yin CC; Medeiros LJ; Bueso-Ramos CE; Tang G Ann Hematol; 2018 Mar; 97(3):425-434. PubMed ID: 29285580 [TBL] [Abstract][Full Text] [Related]
14. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature. Swolin B; Rödjer S; Westin J Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338 [TBL] [Abstract][Full Text] [Related]
15. Leukemic transformation in three patients with polycythemia vera. Analysis of the clinicopathological features and N-ras gene mutation. Sakai H; Karasawa M; Okamoto K; Maehara T; Tsukamoto N; Murakami H; Naruse T; Morita K; Tsuchiya J J Med; 1996; 27(3-4):183-91. PubMed ID: 8982966 [TBL] [Abstract][Full Text] [Related]
16. Transformation of polycythemia vera to acute nonlymphocytic leukemia accompanied by t(1;3)(p36;q21) karyotype. Najfeld V; Coyle T; Berk PD Cancer Genet Cytogenet; 1988 Jul; 33(2):193-200. PubMed ID: 3383167 [TBL] [Abstract][Full Text] [Related]
17. Leukemic transformation of polycythemia vera: a single center study of 23 patients. Passamonti F; Rumi E; Arcaini L; Castagnola C; Lunghi M; Bernasconi P; Giovanni Della Porta M; Columbo N; Pascutto C; Cazzola M; Lazzarino M Cancer; 2005 Sep; 104(5):1032-6. PubMed ID: 16047334 [TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with interferon-alpha in a case of acute myeloid leukemia with del (20q) following polycythemia vera]. Sumi M; Tauchi T; Takaku T; Ohyashiki JH; Ohyashiki K Rinsho Ketsueki; 2005 Nov; 46(11):1208-12. PubMed ID: 16440805 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy. Kiladjian JJ; Gardin C; Renoux M; Bruno F; Bernard JF Hematol J; 2003; 4(3):198-207. PubMed ID: 12764352 [TBL] [Abstract][Full Text] [Related]
20. A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission. Chabannon C; Bost M; Hollard D Leukemia; 1994 Jul; 8(7):1243-4. PubMed ID: 8035619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]